Fed up with delay, Kalburgi's family files plea for SC-monitored probe

Ahmedabad/New Delhi, Jan 22: Interpol has issued a Blue Corner Notice seeking information about controversial self-styled godman Nithyananda, who fled the country amid allegations of wrongful confinement of children, officials said on Wednesday.

A Blue Corner Notice is issued by the international police cooperation body to collect additional information from its member countries about a person's identity, location or activities in relation to a crime.

The Gujarat Police had sent a request to the CBI, the nodal body for Interpol matters in India, seeking a Blue Corner Notice against Nithyananda, the officials said.

"Interpol issued the Blue Corner Notice against the controversial godman this month," Deputy Superintendent of Police, Ahmedabad (rural), K T Kamariya, told PTI.

The police said they are now working to get Interpol to issue a Red Corner Notice, a global arrest warrant, against Nithyananda.

The Gujarat Police had registered an FIR against Nithyananda after two girls went missing from his ashram in Ahmedabad.

He was charged with kidnapping and wrongful confinement of children to make them collect donations from followers to run his ashram.

Nithyananda was earlier declared wanted by the Gujarat Police.

While police continue to look for him, reports emerged in December last year that he has created a Hindu nation, Kailaasa, with its own flag and political setup, on an island near Ecuador.

The United States of America has bought almost the entire world's supply of remdesivir, one of just two drugs proven to treat COVID-19. 

“President Trump has struck an amazing deal to ensure Americans have access to the first authorised therapeutic for Covid-19,” said the US health and human services secretary, Alex Azar. 

“To the extent possible, we want to ensure that any American patient who needs remdesivir can get it. The Trump administration is doing everything in our power to learn more about life-saving therapeutics for Covid-19 and secure access to these options for the American people.”

The announcement implies that no other country in the world will be able to buy remdesivir for next three months at least.

The anti-viral drug patented by the US-based Gilead biotech firm is the only one approved by the European Medicines Agency (EMA) to treat patients with the novel coronavirus.

The Trump administration has already shown that it is prepared to outbid and outmanoeuvre all other countries to secure the medical supplies it needs for the US.

“They’ve got access to most of the drug supply [of remdesivir], so there’s nothing for Europe,” said Dr Andrew Hill, senior visiting research fellow at Liverpool University.

Remdesivir, the first drug approved by licensing authorities in the US to treat Covid-19, is made by Gilead and has been shown to help people recover faster from the disease. 

The first 140,000 doses, supplied to drug trials around the world, have been used up. The Trump administration has now bought more than 500,000 doses, which is all of Gilead’s production for July and 90% of August and September.

Mangaluru, Mar 27: In the wake of coronavirus, the Council of Mangalore City Corporation (MCC) has taken steps to prevent the spread of Covid-19 in the city as a task force has been formed to monitor home delivery of essentials and the situation prevailing in the city due to outbreak of the virus.

MCC commissioner Shanady Ajith Kumar Hegde held a meeting of wholesalers to plan the smooth supply of essentials to the people on Thursday.

Speaking on the occasion, he said, the wholesalers of the city have been directed to supply essential goods to apartments in the city. Each apartment should prepare purchase details and must hand it over to the wholesalers. This way residents will not have to go out to buy essentials. The purchasing time will be between 6 am to 12 pm.